A Sterilizer Got a Two-Year Waiver From the EPA. The Market Noticed.

Key Highlights

• Sotera Health (SHC) closed at $18.15 on July 15, 2026 and traded at $18.16 the next session, up roughly 64% over the trailing year.
• A July 17, 2025 presidential proclamation exempted nine Sterigenics facilities from the EPA's ethylene oxide (EtO) sterilizer rule for two years, citing Clean Air Act national-security and technology-availability provisions.
• EPA proposed on March 12, 2026 to permanently rescind the rule's risk-based emissions standards, which would remove the underlying constraint even after the waiver expires.
• FY2025 revenue reached $1.164 billion, up 5.7% year over year, while net income more than doubled from FY2024, on lighter one-time litigation charges rather than a change in the regulatory backdrop.
• One federal lawsuit, CleanAIRE NC v. Trump, filed January 2026, directly challenges the Sterigenics exemption itself, and a separate October 2025 suit challenging the related HON Rule exemption could set an adverse legal precedent for the same underlying executive authority.

Sotera Health owns Sterigenics, the largest contract sterilizer of medical devices in the country, and for years the stock traded like a legal-liability story more than an industrials story. That changed on July 17, 2025, when the White House signed a proclamation granting nine Sterigenics facilities a two-year exemption from the EPA's ethylene oxide sterilization rule. Shares have climbed from roughly $11 in July 2025 to above $18 by mid-July 2026, and the regulatory mechanics behind that move are still working themselves out in federal court.

The rule, correctly named

The rule that governs Sterigenics is EPA's ethylene oxide emissions standard for commercial sterilization facilities, formally 89 FR 24090, codified at 40 CFR Part 63, Subpart O, and commonly shortened to the "EtO Rule." It is distinct from the Synthetic Organic Chemical Manufacturing Industry rule, sometimes called the "HON Rule," which governs chemical plants, not medical sterilizers. The two get conflated because both received relief the same day, but Sterigenics' business runs under the EtO Rule alone.

EPA finalized the EtO Rule on March 14, 2024, effective April 5, 2024. On March 12, 2025, EPA announced reconsideration and invited facilities to seek exemptions. That led to the July 17, 2025 proclamation (Federal Register, July 23, 2025, 90 FR 34747), naming nine Sterigenics facilities across Georgia, North Carolina, Texas, California, New York, Utah, and New Mexico, each granted a two-year reprieve under Clean Air Act Section 112(i)(4). On March 12, 2026, EPA proposed rescinding the risk-based emissions standards entirely, extending the general compliance deadline to April 5, 2027, and to April 5, 2029 for the exempted facilities.

The financial mechanics

FY2025 revenue was $1.164 billion, up 5.7% from FY2024's $1.100 billion. Net income jumped to $77.9 million from $44.4 million, roughly 75.6% higher, with diluted EPS rising to $0.27 from $0.16. The financial mechanics suggest that acceleration is driven mostly by lower one-time litigation charges rolling off the prior year, not by a change in the regulatory cost structure. Sotera's FY2025 10-K discloses roughly $51 million in environmental compliance capital spending, showing continued investment in emissions controls despite the exemption. Q1 2026 revenue was $280.0 million with net income of $26.6 million, extending the trend ahead of the March 2026 proposal.

The market cap of roughly $5.18 billion against a $1.164 billion revenue base already prices in some expectation that the compliance overhang keeps receding.

Bear case

The Sterigenics exemption is being challenged directly in CleanAIRE NC v. Trump (1:26-cv-00233), filed January 28, 2026 before Judge Christopher Cooper in the D.D.C. A separate case, 1:25-cv-03745, filed October 22, 2025, challenges the sister proclamation covering HON Rule chemical plants, not Sterigenics itself, but both proclamations rely on the same Clean Air Act Section 112(i)(4) national-security authority, so a ruling against one could weaken the legal footing of the other. A court vacating the Sterigenics proclamation could snap the original deadlines back into force, forcing accelerated spending Sotera has so far deferred. EPA's March 2026 proposal is itself unfinalized. None of the stock's 64% one-year gain is contractually locked in.

Investment Idea: Sotera Health Company (SHC)

Thesis type: Deregulatory tailwind, single-company.

Deregulatory catalyst: July 17, 2025 proclamation (90 FR 34747) exempting nine Sterigenics facilities from the EtO Rule, followed by EPA's March 12, 2026 proposal to rescind the underlying standard.

Current price: $18.16 (July 16, 2026).

Key financial data: FY2025 revenue $1.164 billion (+5.7% YoY); net income $77.9 million (+75.6% YoY); diluted EPS $0.27; market cap approximately $5.18 billion; trailing P/E approximately 20.2x.

Regulatory constraint removed: A binding compliance deadline requiring immediate capital investment at nine facilities has been delayed by presidential action, with a parallel EPA proposal aiming to remove the standard altogether.

Bull case: Capital spending is spread out to 2029 at the earliest, and if EPA's proposal finalizes, some may never be required at the original level. The historical base rate for relief reinforced by a follow-on rulemaking is that it tends to persist absent a successful court challenge.

Bear case: CleanAIRE NC v. Trump creates direct binary tail risk to the Sterigenics exemption itself; the separate HON Rule case creates indirect precedent risk to the same legal authority. Either an adverse ruling could restore the original schedule with less lead time.

What to watch: CleanAIRE NC v. Trump (1:26-cv-00233) directly, Case 1:25-cv-03745 for precedent risk, and whether EPA finalizes its March 2026 proposal after the comment period closes.

Time horizon: 12 to 24 months, tracking the litigation calendar and EPA's rulemaking timeline through the 2027 and 2029 deadlines.

The principle

Deregulation rarely arrives as one clean event. It arrives as a sequence: a rule, a reconsideration, an exemption, a follow-on rulemaking, and, almost always, a lawsuit contesting each step. Sotera Health's run over the past year is a case study in what that sequence looks like from the equity side. The historical base rate favors relief that survives long enough to matter economically, but the two pending court cases are a reminder that regulatory tailwinds carry a legal expiration date until they don't.

Footnotes

1. U.S. EPA, "Final Rule Fact Sheet: Ethylene Oxide Emissions Standards for Sterilization Facilities," March 14, 2024. https://www.epa.gov/system/files/documents/2024-03/factsheet_etosterilizers_final_3-14-24.pdf
2. SCS Engineers, "EtO Rule Imposes Clean Air Act Compliance on Commercial Sterilization Facilities." https://www.scsengineers.com/eto-rule-imposes-clean-air-act-compliance-commercial-sterilization-facilities/
3. McGuireWoods, "EPA Reconsiders NESHAPs: Key Changes and Industry Impacts," March 2025. https://www.mcguirewoods.com/client-resources/alerts/2025/3/epa-reconsiders-neshaps-key-changes-and-industry-impacts-for-the-hon-rule/
4. Harvard Environmental & Energy Law Program, Regulatory Rollback Tracker, "Ethylene Oxide (EtO) Emissions Standards for Commercial Sterilizers." https://eelp.law.harvard.edu/tracker/ethylene-oxide-eto-emissions-standards-for-commercial-sterilizers/
5. The White House, "Regulatory Relief for Certain Stationary Sources to Promote American Security With Respect to Sterile Medical Equipment," July 17, 2025 (published Federal Register July 23, 2025, 90 FR 34747). https://www.whitehouse.gov/presidential-actions/2025/07/regulatory-relief-for-certain-stationary-sources-to-promote-american-security-with-respect-to-sterile-medical-equipment/
6. GovInfo.gov, Federal Register 90 FR 34587, "Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security." https://www.govinfo.gov/content/pkg/FR-2025-07-23/html/2025-13890.htm
7. U.S. EPA-hosted complaint, Case No. 1:25-cv-03745 (D.D.C.), filed October 22, 2025. https://www.epa.gov/system/files/documents/2026-03/25-3745.pdf
8. Civil Rights Litigation Clearinghouse, Case Tracker, CleanAIRE NC v. Trump, No. 1:26-cv-00233 (D.D.C.). https://clearinghouse.net/case/47775/
9. U.S. EPA, Proposed Rule Preamble, "Ethylene Oxide Emissions Standards for Sterilization Facilities: Reconsideration," March 12, 2026 (Docket EPA-HQ-OAR-2019-0178). https://www.epa.gov/system/files/documents/2026-03/7055.1-eto-sterilizers-proposal-preamble-20260312_admin_forweb_0.pdf
10. Sotera Health Co., FY2025 Form 10-K (via StockTitan SEC filing summary). https://www.stocktitan.net/sec-filings/SHC/10-k-sotera-health-co-files-annual-report-33217422060b.html
11. Perplexity Finance, finance_quotes and finance_company_financials data for SHC, fetched July 16, 2026.

The Free Markets Report is provided by Lead-Lag Publishing, LLC. All opinions and views mentioned in this report constitute our judgments as of the date of writing and are subject to change at any time. Information within this material is not intended to be used as a primary basis for investment decisions, and should also not be construed as advice meeting the particular investment needs of any individual investor. Trading signals produced by The Free Markets Report are independent of other services provided by Lead-Lag Publishing, LLC, or its affiliates, and the positioning of accounts under their management may differ. Please remember that investing involves risk, including loss of principal, and past performance may not be indicative of future results. Lead-Lag Publishing, LLC, its members, officers, directors, and employees expressly disclaim all liability with respect to actions taken based on any or all of the information in this writing.